Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Clinical correlates, prognostic impact and survival outcomes in chronic myelomonocytic leukemia patients with the JAK2V617F mutation.

Patnaik MM, Pophali PA, Lasho TL, Finke CM, Horna P, Ketterling RP, Gangat N, Mangaonkar AA, Pardanani A, Tefferi A.

Haematologica. 2019 Jun;104(6):e236-e239. doi: 10.3324/haematol.2018.208082. Epub 2019 Jan 3. No abstract available.

2.

The association of physical activity before and after lymphoma diagnosis with survival outcomes.

Pophali PA, Ip A, Larson MC, Rosenthal AC, Maurer MJ, Flowers CR, Link BK, Farooq U, Feldman AL, Allmer C, Slager SL, Witzig TE, Habermann TM, Cohen JB, Cerhan JR, Thompson CA.

Am J Hematol. 2018 Dec;93(12):1543-1550. doi: 10.1002/ajh.25288. Epub 2018 Oct 17.

PMID:
30230581
3.

Prevalence and survival of smouldering Waldenström macroglobulinaemia in the United States.

Pophali PA, Bartley A, Kapoor P, Gonsalves WI, Ashrani AA, Marshall AL, Siddiqui MA, Kyle RA, Go RS.

Br J Haematol. 2019 Mar;184(6):1014-1017. doi: 10.1111/bjh.15201. Epub 2018 Mar 13. No abstract available.

PMID:
29532912
4.

Risks factors and timing of genital human papillomavirus (HPV) infection in female stem cell transplant survivors: a longitudinal study.

Shanis D, Anandi P, Grant C, Bachi A, Vyas N, Merideth MA, Pophali PA, Koklanaris E, Ito S, Savani BN, Barrett AJ, Battiwalla M, Stratton P.

Bone Marrow Transplant. 2018 Jan;53(1):78-83. doi: 10.1038/bmt.2017.210. Epub 2017 Oct 16.

PMID:
29035398
5.

Early stage, bulky Hodgkin lymphoma patients have a favorable outcome when treated with or without consolidative radiotherapy: potential role of PET scan in treatment planning.

Nguyen VT, Pophali PA, Tsai JP, Jagadeesh D, Dean RM, Pohlman B, Morgan DS, Greer JP, Smith MR, Hill BT, Reddy NM.

Br J Haematol. 2017 Nov;179(4):674-676. doi: 10.1111/bjh.14236. Epub 2016 Jul 13. No abstract available.

PMID:
27409578
6.

Factors influencing the late phase of recovery after bone mineral density loss in allogeneic stem cell transplantation survivors.

Anandi P, Jain NA, Tian X, Wu CO, Pophali PA, Koklanaris E, Ito S, Savani BN, Barrett J, Battiwalla M.

Bone Marrow Transplant. 2016 Aug;51(8):1101-6. doi: 10.1038/bmt.2016.85. Epub 2016 Apr 4.

PMID:
27042843
7.

The Role of New Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia.

Pophali PA, Patnaik MM.

Cancer J. 2016 Jan-Feb;22(1):40-50. doi: 10.1097/PPO.0000000000000165. Review.

8.

Contrast enhanced cardiac CT reveals coronary artery disease in 45% of asymptomatic allo-SCT long-term survivors.

Jain NA, Chen MY, Shanbhag S, Lu K, Pophali PA, Ito S, Koklanaris E, Hourigan CS, Barrett AJ, Battiwalla M.

Bone Marrow Transplant. 2014 Mar;49(3):451-2. doi: 10.1038/bmt.2013.182. Epub 2013 Nov 18. No abstract available.

9.

Repair of impaired pulmonary function is possible in very-long-term allogeneic stem cell transplantation survivors.

Jain NA, Pophali PA, Klotz JK, Ito S, Koklanaris E, Chawla K, Hourigan CS, Gormley N, Savani BN, Barrett AJ, Battiwalla M.

Biol Blood Marrow Transplant. 2014 Feb;20(2):209-13. doi: 10.1016/j.bbmt.2013.10.025. Epub 2013 Nov 2.

10.

Male survivors of allogeneic hematopoietic stem cell transplantation have a long term persisting risk of cardiovascular events.

Pophali PA, Klotz JK, Ito S, Jain NA, Koklanaris E, Le RQ, Hourigan CS, Savani BN, Chawla K, Shanbhag S, Barrett AJ, Battiwalla M.

Exp Hematol. 2014 Feb;42(2):83-9. doi: 10.1016/j.exphem.2013.07.003. Epub 2013 Oct 17.

11.

Radiation exposure from diagnostic procedures following allogeneic stem cell transplantation--how much is acceptable?

Battiwalla M, Fakhrejahani F, Jain NA, Klotz JK, Pophali PA, Draper D, Haggerty J, McIver Z, Jelinek J, Chawla K, Ito S, Barrett J.

Hematology. 2014 Jul;19(5):275-9. doi: 10.1179/1607845413Y.0000000131. Epub 2013 Nov 25.

Supplemental Content

Loading ...
Support Center